AI summary by TwinMind
Why is it so hard to cure the common cold?
TED-Ed
5m 17s
ViroPharma Pleconaril Clinical Trial (2000)
- ViroPharma tested pleconaril pill for common cold treatment
- Drug helped many patients initially
- 7 patients developed mutated virus variants almost completely resistant to pleconaril within days
- Virus mutated faster than years of R&D could anticipate
Common Cold Biology and Immune Response
- Without immune system: cold spreads to lungs → tissue destruction → asphyxiation
- Millions with compromised immunity/immunosuppressants face deadly risk from "minor" infections
- Healthy adults catch 150+ colds lifetime
- 8+ different virus families cause colds, each with species/subtypes
- Viruses enter via breathing → immune system frontline defenses create symptoms:
- Mucus/dripping nose: traps and flushes virus
- Fever: raises temperature to slow viral replication
- Inflammation: widens blood vessels, recruits white blood cells
Rhinovirus as Primary Target
- Single family causes 30-50% of all colds: rhinovirus
- Eliminating rhinovirus would significantly impact common cold
Vaccine Development Attempts
- Two main approaches: vaccines and antiviral drugs
- William Price 1957 rhinovirus vaccine trial:
- 50 vaccinated kids vs 50 placebo
- Rhinovirus outbreak occurred
- Vaccinated group: 3 got sick
- Placebo group: 23 got sick (8x higher rate)
- Later trials showed zero protection
- Problem: rhinovirus has 169+ subtypes
- Price's vaccine only protected against 1-few subtypes, not broadly protective
Vaccine Success Examples and Challenges
- mRNA COVID vaccines: broad protection against original virus and variants
- No broadly protective vaccine exists for rhinovirus or other cold viruses
Antiviral Drug Challenges
- Viruses hijack human cellular machinery
- Difficult creating molecules toxic to virus but not human
- Viruses can mutate away from drug effectiveness
- Example: pleconaril resistance developed rapidly
Historical Viral Combat Success Stories
- Smallpox eradication: effective vaccine + no animal reservoir + low mutation rate
- HIV: extremely high mutation rate (every possible single-letter mutation possible daily in untreated individual)
- No vaccine after decades of attempts
- Effective drug cocktail prevents easy mutation escape
Future Prospects
- Currently stuck with colds
- Recent breakthroughs: mRNA vaccines, CRISPR
- CRISPR potential as antiviral:
- Originally evolved in bacteria as viral defense
- COVID-19 pandemic research: CRISPR degraded coronavirus/influenza genomes in lung cells
- System called PAC-MAN (Prophylactic Antiviral CRISPR in huMAN cells)
